Insmed Incorporated
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 188.46M | 245.36M | 305.21M | 363.71M | 606.42M | 66.7% | |
| Cost of Revenue | (44.15M) | (55.13M) | (65.57M) | (85.74M) | (124.88M) | 45.6% | |
Gross Profit | 144.31M | 190.23M | 239.63M | 277.96M | 481.55M | 73.2% | |
| Operating Expenses | |||||||
| Research & Development | (272.74M) | (397.52M) | (571.01M) | (598.37M) | (771.09M) | 28.9% | |
| Selling, General & Administrative | (234.27M) | (265.78M) | (344.50M) | (461.12M) | (701.17M) | 52.1% | |
| General & Administrative | (234.27M) | (265.78M) | (344.50M) | (461.12M) | (701.17M) | 52.1% | |
| Depreciation & Amortization | (14.18M) | (10.33M) | (10.58M) | (11.01M) | (16.45M) | 49.4% | |
Operating Income (EBIT) | -375.09M | -457.32M | -709.63M | -878.25M | -1.18B | 34.0% | |
| Non-Operating Items | |||||||
| Interest Income | 174.00K | 11.08M | 42.13M | 53.31M | 60.66M | 13.8% | |
| Interest Expense | (40.47M) | (26.45M) | (81.69M) | (84.91M) | (83.80M) | -1.3% | |
| Other Income/Expenses (Net) | -61.32M | -22.83M | -37.39M | -31.81M | -95.02M | 198.7% | |
Income Before Tax | -436.41M | -480.15M | -747.01M | -910.07M | -1.27B | 39.7% | |
| Income Tax Expense | (1.76M) | (1.38M) | (2.56M) | (3.71M) | (5.03M) | 35.6% | |
Net Income | -434.65M | -481.53M | -749.57M | -913.77M | -1.28B | 39.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-4 | $-4 | $-5 | $-6 | $-6 | 15.1% | |
| Weighted Avg Shares Outstanding | 112.11M | 123.03M | 140.43M | 164.04M | 213.64M | 30.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 112.11M | 123.03M | 140.43M | 164.04M | 213.64M | 30.2% | |
EBITDA | -383.65M | -447.37M | -660.18M | -818.79M | -1.17B | 43.1% |
Explore INSM
INSM in the Healthcare
Large Cap